Bioceltix SA (BCXP)

Currency in PLN
102.80
-3.00(-2.84%)
Closed·
BCXP Scorecard
Full Analysis
Suffers from weak gross profit margins
BCXP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
100.40105.80
52 wk Range
63.00129.00
Key Statistics
Bid/Ask
102.00 / 102.80
Prev. Close
105.8
Open
105.8
Day's Range
100.4-105.8
52 wk Range
63-129
Volume
4.33K
Average Volume (3m)
7.12K
1-Year Change
51.18%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BCXP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
110.00
Upside
+7.00%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Bioceltix SA Company Profile

Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. Its products include BCX-CM-J, a stem-cell based biological drug for the treatment of degenerative joint lesions in dogs; BCX-CM-AD, a biological drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a biological drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was incorporated in 2018 and is based in Wroclaw, Poland.

Employees
35
Market
Poland

Compare BCXP to Peers and Sector

Metrics to compare
BCXP
Peers
Sector
Relationship
P/E Ratio
−34.9x−5.2x−0.5x
PEG Ratio
−1.880.010.00
Price/Book
14.6x2.3x2.6x
Price / LTM Sales
-10.5x3.3x
Upside (Analyst Target)
7.0%74.6%45.4%
Fair Value Upside
Unlock0.6%7.7%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 110.00
(+7.00% Upside)

Earnings

Latest Release
May 28, 2025
EPS / Forecast
-0.77 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

BCXP Income Statement

People Also Watch

134.10
RBW
+0.37%
11.97
PGE
-1.16%
405.00
KRU
-1.70%
14.420
MRB
-3.61%
82.45
PKN
-1.45%

FAQ

What Stock Exchange Does Bioceltix Trade On?

Bioceltix is listed and trades on the Warsaw Stock Exchange stock exchange.

What Is the Stock Symbol for Bioceltix?

The stock symbol for Bioceltix is "BCXP."

What Is the Bioceltix Market Cap?

As of today, Bioceltix market cap is 506.24M.

What Is Bioceltix's Earnings Per Share (TTM)?

The Bioceltix EPS (TTM) is -3.06.

When Is the Next Bioceltix Earnings Date?

Bioceltix will release its next earnings report on 02 Sept 2025.

From a Technical Analysis Perspective, Is BCXP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Bioceltix Stock Split?

Bioceltix has split 0 times.

How Many Employees Does Bioceltix Have?

Bioceltix has 35 employees.

What is the current trading status of Bioceltix (BCXP)?

As of 03 Aug 2025, Bioceltix (BCXP) is trading at a price of 102.80, with a previous close of 105.80. The stock has fluctuated within a day range of 100.40 to 105.80, while its 52-week range spans from 63.00 to 129.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.